Sterlite Technologies Target Price Outlook After Q2

Market reaction puts Sterlite Technologies in focus

Social-media discussion has focused on sharply higher brokerage targets for Sterlite Technologies. Shares reportedly gained 2% after CLSA raised its target price to Rs 1,400. A separate update said the stock hit a 5% upper circuit after FY29 targets were unveiled. The central themes are AI data centres, hyperscalers and optical-fibre demand. Reports also point to planned capacity expansion and a larger order book. The supplied material contains different price snapshots from different reporting points. One snapshot showed Rs 867.55, while another showed a last close of Rs 829. These figures should not be read as a single live market quotation. The brokerage upside calculations also use different reference prices.

Brokerage target prices span a wide range

CLSA is reported to have raised its target price to Rs 1,610 from Rs 1,400. The CLSA update described in the discussion retained an Accumulate rating. Earlier material had cited an Outperform rating and a Rs 1,400 target. Nomura initiated coverage with a Buy rating and a Rs 1,350 target. Nomura later maintained its Buy view and the same Rs 1,350 target. Nuvama Institutional Equities reportedly reiterated Buy and lifted its target to Rs 1,460. Nirmal Bang maintained Buy and raised its target to Rs 1,544. A reported three-analyst consensus showed a Buy view and a Rs 1,473.33 average target.

Why analysts revised their estimates

CLSA reportedly increased its FY27-FY29 estimates by 5% to 40% after the quarterly performance. The brokerage expects a 104% EBITDA compound annual growth rate through FY29. Nomura cited stronger optical-fibre cable demand and better profitability prospects. Nirmal Bang highlighted front-loaded delivery and sustained high-margin growth. Analysts linked the opportunity to global hyperscale data-centre capital expenditure. They said hyperscaler orders had changed the company’s growth trajectory. The same commentary flagged possible medium-term moderation in data-centre spending across the industry. The positive case therefore rests heavily on accelerated execution of Sterlite’s order book.

Q2 FY27 performance shaped the latest debate

Sterlite Technologies reportedly delivered a strong Q2 FY27 performance. Revenue was stated at Rs 2,529 crore, up 144.6% year on year. Reported demand drivers included AI data centres, telecom networks and FTTx. Commentary also cited optical-networking growth and improved pricing. Nomura pointed to the quarterly result while maintaining its Buy recommendation. Consensus FY27 revenue expectations reportedly rose to Rs 90.7 billion from Rs 80.7 billion. The EPS estimate was raised to Rs 20.42 from Rs 16.50 per share. These are analyst forecasts rather than company-reported financial results.

Order book visibility supports the growth case

The discussion cited H1FY27 order intake of Rs 32,030 crore. It also cited a record order book of Rs 35,270 crore. That order book included a five-year hyperscaler agreement worth Rs 11,500 crore. Another brokerage note put the order book at about Rs 35,200 crore. That note said Rs 3,000 crore was executable in Q3 FY27. The remaining value was described as spread over the following nine quarters. It indicated an average quarterly execution run rate of Rs 3,000 crore to Rs 3,200 crore. The small variation in reported order-book figures reflects different updates in the supplied material.

Data-centre exposure is a key revenue driver

Management expects Data Centre and Cloud to contribute 50% of FY27 revenue. This expectation reflects the AI-led demand theme highlighted by analysts. Connectivity attach rates are targeted to rise above 25%. The reported attach rate was 24% in H1FY27. Brokerages see data-centre rollouts as supportive of optical-fibre cable demand. They also expect hyperscaler business to support order execution. The company’s FY29 revenue aspiration is Rs 20,000 crore. Management has also outlined an ambition to become a global top-five player.

Capacity expansion requires sustained capital spending

CLSA expects Sterlite Technologies’ capacity to expand 50% by FY29. The expansion is backed by Rs 3,000 crore of approved capital expenditure, according to the discussion. Another report said the company plans to invest Rs 1,000 crore annually from FY27 to FY29. That programme includes a new pre-terminated solutions facility. Nomura also identified planned capacity expansion as a revenue and margin driver. More capacity can support delivery against the reported order book. However, the investment plan will need to translate into timely commissioning and execution. The supplied commentary does not provide a detailed project-by-project spending schedule.

How to read the reported upside figures

At least four brokerages were said to see upside of as much as 95%. CLSA’s Rs 1,610 target was described as implying 46% upside from then-recent levels. Nomura’s Rs 1,350 target was separately described as implying 25.5% upside. Nirmal Bang’s Rs 1,544 target was described as implying about 87% upside in another report. An earlier CLSA Rs 1,400 target implied 55.55% upside in the supplied material. Nomura’s initiation target was also described as implying 48.5% upside. These percentages are based on different share-price reference points. Comparing target prices and their publication dates is more useful than comparing headline upside numbers alone.

Outlook depends on execution and demand durability

The current analyst case is built around quarterly momentum, order visibility and capacity expansion. AI data centres and hyperscaler demand are the principal growth drivers in the discussion. Stronger margins are also part of the brokerage forecasts. Yet industry commentary has warned of possible moderation in data-centre spending over the medium term. Execution of the large reported order book remains central to the outlook. Capacity additions and the new solutions facility will also be important milestones. Brokerages will likely reassess their assumptions as revenue mix and order conversion develop. A target price is an analyst valuation estimate, not a guaranteed future market price.